Turning Point Therapeutics, Inc.

United States of America


 
Total IP 99
Total IP Rank # 13,365
IP Activity Score 2.9/5.0    109
IP Activity Rank # 6,356
Stock Symbol TPTX (nasdaq)
ISIN US90041T1088
Market Cap. 4,700M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

27 19
10 17
8 3
15
 
Last Patent 2024 - Macrocyclic compounds and uses t...
First Patent 2015 - Diaryl macrocycles as modulators...
Last Trademark 2025 - AUGTYRO
First Trademark 2018 - TURNING POINT THERAPEUTICS

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Pharmaceutical preparations for the treatment of cancer.
G/S Pharmaceutical preparations for the treatment of cancer
2024 G/S Pharmaceutical preparations for the treatment of cancer
Invention Macrocyclic compounds and uses thereof. The present disclosure relates to certain macrocyclic co...
2023 G/S Pharmaceutical and biological preparations for human use.
G/S Pharmaceutical preparations for the treatment of cancer;
Invention Diaryl macrocycles as modulators of protein kinases. The present invention relates to certain di...
G/S Pharmaceutical and biological preparations for human use;
G/S Pharmaceutical and biological preparations for human use.
G/S harmaceutical and biological preparations for human use.
Invention Combination therapy involving diaryl macrocyclic compounds. The present disclosure relates to me...
Invention Macrocycles for use in treating disease. The present disclosure relates to certain chiral diaryl...
G/S Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinen...
2022 Invention Synthesis of macrocyclic compounds. The present disclosure provides new methods of preparing a co...
Invention Diaryl macrocycle polymorph. This disclosure relates to polymorphs of (7S,13R)-11-fluoro-7,13-dim...
Invention Chiral diaryl macrocycles and uses thereof. This disclosure relates to the use of certain diaryl ...
G/S Pharmaceutical preparations for the treatment of cancer.
Invention Macrocyclic compounds and uses thereof. The present disclosure relates to certain macrocyclic com...
Invention Macrocyclic compounds for treating disease. The present disclosure relates to certain macrocycli...
2021 Invention Macrocycles for use in treating disease. The present disclosure relates to certain chiral diaryl ...
Invention Therapeutic uses of macrocyclic compounds. This disclosure relates to the use of certain diaryl m...
2020 Invention Macrocycles for use in treating disease. The present disclosure relates to certain diaryl macrocy...
Invention Combination therapy involving diaryl macrocyclic compounds. The present disclosure relates to met...
Invention Diaryl macrocycle polymorph. This disclosure relates to polymorphs of (7S,13R)-11-fluoro-7,13-di...
Invention Polymorphs of a macrocyclic kinase inhibitor. This disclosure relates to polymorphs of (3aR,11S,...
Invention Polymorphs of a macrocyclic kinase inhibitor. This disclosure relates to polymorphs of (3aR,11S,2...
Invention Macrocycles for treating disease. The present disclosure relates to certain macrocyclic derivativ...
Invention Polymorphs of a macrocyclic kinase inhibitor. aRSSaHHilHH)-one that are useful in the treatment o...
Invention Macrocyclic compounds for treating disease. The present disclosure relates to certain macrocyclic...
2019 Invention Chiral diaryl macrocycles as modulators of protein kinases. The present disclosure relates to cer...
2018 Invention Macrocyclic kinase inhibitors and their use. The present disclosure relates to certain chiral di...
Invention Diaryl macrocycles as modulators of protein kinases. The present invention relates to certain dia...
2017 Invention Macrocycle kinase inhibitors. The present disclosure relates to certain macrocyclic kinase inhibi...
2016 Invention Chiral diaryl macrocycles and uses thereof. This disclosure relates to the use of certain diaryl...